Silicon Laboratories, Inc. SLAB
221.24
(0.14)
(0.06%)
as of 25 Sep
- Market cap
- $7.4B
- P/E
- 0.0×
Follow SLAB
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (3.63%) | (4.65%) | (5.97%) | (8.00%) |
+8 more TTM periods Free account |
|
| (3.16%) | (4.03%) | (5.21%) | (6.88%) | ||
ROIC |
(3.88%) | (5.26%) | (6.77%) | (9.49%) | |
Return on Tangible Assets |
(5.77%) | (7.45%) | (9.85%) | (13.54%) | |
Average Days of Receivables |
34.03 | 34.30 | 30.01 | 33.07 | |
Free Cash Flow per Share |
(0.16) | 0.53 | 2.01 | 1.86 | |
Free Cash Flow |
(5.43) | 17.61 | 65.79 | 61.20 | |
Capital Expenditures |
(38.53) | (34.91) | (29.92) | (36.29) | |
Piotroski F-Score |
6.00 | 5.00 | 5.00 | 5.00 | |
| Other line items | |||||
Cash ROIC |
2.22% | 3.42% | 6.22% | 6.46% | |
Accounts Receivable Turnover |
12.56 | 12.70 | 13.19 | 12.79 | |
Accounts Payable Turnover |
6.10 | 6.07 | 7.04 | 6.53 | |
Inventory Turnover |
3.30 | 3.58 | 3.26 | 2.96 | |
Average Days of Payables |
56.74 | 61.55 | 56.48 | 61.98 | |
Days of Inventory on Hand |
133.54 | 112.70 | 106.42 | 91.55 | |
Tax Rate |
0.22 | 0.17 | 0.12 | 0.03 | |
Research and Development Expense of Revenue |
42.16% | 43.10% | 45.01% | 46.60% | |
Selling, General and Administrative Expense of Revenue |
23.52% | 22.93% | 22.21% | 22.20% | |
Share Based Compensation of Revenue |
10.21% | 9.95% | 10.24% | 10.20% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(0.85) | (1.04) | (1.47) | (1.13) | |
Depreciation/Fixed assets |
0.25 | 0.26 | 0.30 | 0.32 | |
Capex/Depreciation |
(1.15) | (1.00) | (0.79) | (0.87) | |
Revenue per Share |
25.78 | 24.89 | 23.98 | 22.62 | |
Operating CF per Share |
1.00 | 1.59 | 2.93 | 2.97 | |
Capex per Share |
(1.16) | (1.06) | (0.91) | (1.11) | |
Capex to Sales |
0.05 | 0.04 | 0.04 | 0.05 | |
Net Profit Margin |
(4.57%) | (6.13%) | (8.27%) | (11.58%) |
Columns are period end dates